Shepherd Kaplan Krochuk’s Genomic Health, Inc. GHDX Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,256	Closed	-$383K	–	383
2016 Q3	$383K	Hold	13,256	–	–	0.08%	166
2016 Q2	$343K	Hold	13,256	–	–	0.09%	166
2016 Q1	$328K	Buy	13,256 +5,998	+83%	+$165K	0.1%	152
2015 Q4	$255K	Buy	+7,258	New	+$194K	0.07%	224
2015 Q3	–	Sell	-7,258	Closed	-$202K	–	483
2015 Q2	$202K	Hold	7,258	–	–	0.04%	315
2015 Q1	$222K	Buy	+7,258	New	+$231K	0.04%	276

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Shepherd Kaplan Krochuk's GHDX Position: Q4 2016 in Review

Shepherd Kaplan Krochuk sold out of Genomic Health, Inc. (GHDX) in Q4 2016, closing a stake of 13,256 shares — an estimated $383K sold.

Shepherd Kaplan Krochuk first reported a position in GHDX in Q1 2015 and held it in 6 quarters. The position peaked at $383K in Q3 2016. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

Shepherd Kaplan Krochuk reported no remaining Genomic Health, Inc. position as of Q4 2016 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 13,256 Genomic Health, Inc. shares in Q4 2016, an estimated $383K.
Shepherd Kaplan Krochuk first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 6 quarters.
Shepherd Kaplan Krochuk's Genomic Health, Inc. position peaked at $383K in Q3 2016.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2016, filed 10 Feb 2017.